| Literature DB >> 34883668 |
Rui Li1, Mengying Zhang1, Yulin Wu1, Peixin Tang2, Gang Sun2, Liwen Wang1, Sumit Mandal3, Lizhi Wang4, James Lang5, Alberto Passalacqua6, Shankar Subramaniam6, Guowen Song1.
Abstract
Infectious respiratory diseases such as the current COVID-19 have caused public health crises and interfered with social activity. Given the complexity of these novel infectious diseases, their dynamic nature, along with rapid changes in social and occupational environments, technology, and means of interpersonal interaction, respiratory protective devices (RPDs) play a crucial role in controlling infection, particularly for viruses like SARS-CoV-2 that have a high transmission rate, strong viability, multiple infection routes and mechanisms, and emerging new variants that could reduce the efficacy of existing vaccines. Evidence of asymptomatic and pre-symptomatic transmissions further highlights the importance of a universal adoption of RPDs. RPDs have substantially improved over the past 100 years due to advances in technology, materials, and medical knowledge. However, several issues still need to be addressed such as engineering performance, comfort, testing standards, compliance monitoring, and regulations, especially considering the recent emergence of pathogens with novel transmission characteristics. In this review, we summarize existing knowledge and understanding on respiratory infectious diseases and their protection, discuss the emerging issues that influence the resulting protective and comfort performance of the RPDs, and provide insights in the identified knowledge gaps and future directions with diverse perspectives.Entities:
Keywords: biocidal material; decontamination; filtration; fit; healthcare worker; respiratory protective device
Year: 2021 PMID: 34883668 PMCID: PMC8659889 DOI: 10.3390/polym13234165
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1Emerging novel respiratory infectious diseases over the last two decades.
Figure 2Interacting factors for different hazardous environments, respiratory protective devices (RPDs), and end users and their impact on protective performance and comfort.
Figure 3Impacts of particle size and type of filtration mechanism on RPD filtration efficiency.
Environmental and human factors that influence RPD filtration efficiency.
| Influencing Factors | Filtration Efficiency Change | Reference |
|---|---|---|
| Particle size | With decreasing particle size, the filtration efficiency starts to decrease before increasing again ( | [ |
| Airflow rate/face velocity | The higher the airflow rate, the lower the filtration efficiency | [ |
| Breathing pattern | Unsteady breathing pattern reduces filtration efficiency | [ |
| Respiration frequency | Higher respiration frequency reduces filtration efficiency | [ |
| Humidity | Higher humidity reduces filtration efficiency | [ |
| Loading time | Longer loading time increases filtration efficiency | [ |
FFR regulations, specifications, and test methods [54,97,98,99,100].
| Specified Performance | United States | European Union | ||
|---|---|---|---|---|
| Regulation/Guidance: | Regulation/Guidance: | |||
| Requirements: | Test Methods | Requirements: | Test Methods | |
| Particulates filtration efficiency (%) | N95 R95 P95 ≥ 95 | TEB-APR-STP-0051 to 0059 | FFP1 ≥ 80 | EN 149 +A1 |
| Total inward leakage (TIL, %) | NA | NA | FFP1 ≤ 22 | EN 149 +A1 |
| Breathing resistance (inhalation) | All N, R, P series ≤ 35 mm H2O (343 Pa) | TEB-APR-STP-0007 | FFP1 ≤ 0.6 (mbar, 60 Pa) and 2.1 (210) | EN 149 +A1 |
| Breathing resistance (exhalation) | All N, R, P series ≤ 25 mm H2O (245 Pa) | TEB-APR-STP-0003 | FFP 1, 2, 3 ≤ 3 mbar (300 Pa) | EN 149 +A1 |
| Exhalation valve leakage | Leakage ≤ 30 mL/min | TEB-APR-STP-0004 | NA | NA |
| CO2 content requirement (%) | NA | NA | FFP 1, 2, 3 ≤ 1 | EN 149 +A1 |
| Flammability | NA | NA | Pass | EN 149 +A1 |
| Biocompatibility | NA | NA | Pass | ISO 10993-1 |
Surgical/medical mask regulations, specifications, and test methods [97,100,101,102,103,104,105,106,107,108,109].
| Specified Performance | United States | European Union | ||
|---|---|---|---|---|
| Regulation/Guidance: | Regulation/Guidance: | |||
| Requirements: | Test Methods | Requirements: | Test Methods | |
| Sub-micron particulates filtration efficiency, 0.1 µm (%) | Level 1 ≥ 95 | ASTM F2299 | NA | NA |
| Bacterial filtration efficiency, 3 µm (%) | Level 1 ≥ 95 | ASTM F2101 | Type I ≥ 95 | EN 14,683 + AC Annex B |
| Differential pressure, Pa/cm2 (mmH2O/cm2) | Level 1 < 50 (5) | EN 14,683 + AC | Type I < 40 (4) | EN 14,683 + AC |
| Synthetic blood/splash resistance, mmHg (KPa) | Level 1 ≥ 80 (11) | ASTM F1862 | Type I NA | ISO 22609 |
| Flammability | Level 1–3 to be Class 1 | 16 CFR 1610 | NA | NA |
| Microbial cleanliness (cfu/g) | NA | NA | Type I ≤ 30 | ISO 11737-1 |
| Biocompatibility | NA | FDA recommends following ISO 10993 | Pass | ISO 10993-1 |
| Viral filtration efficiency, 3 µm | No standard | Adapted ASTM F2101 using | NA | NA |
Summary of filtration efficiency evaluations of the various materials used to fabricate homemade mask/face coverings.
| Tested Items | Test Condition | Results | Conclusions |
|---|---|---|---|
| N95 filter media, cloth masks, sweatshirts, T-shirts, towels, scarfs | In both flowrate conditions, N95 filter media had less than 4% penetration, while other tested items had 40–90% penetration for polydisperse particles and 9–98% penetration for various sizes of monodisperse particles | Common fabric material only provides marginal protection against small particles, filtration efficiency for different particle sizes varies significantly [ | |
| Surgical mask, T-shirt, scarf, tea towel, pillowcase, vacuum cleaner bag, cotton mix, linen, silk | For bacterial aerosol, filtration efficiency ranged from 58% to 96%; for viral aerosol, filtration efficiency ranged from 51% to 90% | Surgical mask, double layer tea towel, and vacuum cleaner bag had similar filtration efficiencies (>94% for bacteria; >85% for viruses); double layer T-shirt did not offer any improvement over single layer [ | |
| N95 masks, surgical masks, cloth masks | Cloth mask filtration efficiencies ranged from 15–57% for diesel particles and 39% to 65% for latex particles; disposable surgical masks had efficiencies of 78–94% for latex and 79% for diesel particles. | N95 masks were effective at removing most test particles; surgical masks were surprisingly effective for all test particles; cloth masks only had a marginal filtration efficiency [ | |
| N95 masks, | At the lower flow rate, several fabrics achieved the same filtration efficiency as N95 and surgical masks (75–99%); at the higher flow rate, N95 maintains a high efficiency (>94%) while the other materials exhibit a significantly reduced efficiency (14–64%), especially for particles <300 nm | At the lower flow rate, fabric combinations such as cotton-silk, cotton-chiffon, and cotton-flannel had filtration efficiencies above 80% irrespective of the particle size; the number of fabric layers and the fabric density (i.e., threads per inch) both affected filtration efficiency [ |
Figure 4Schematic to illustrate the transport processes of virus-laden droplets in the human-mask-environment system.
Figure 5Transport of droplets in the air as a multi-phase flow.
Past research using modeling and other simulation approaches to link human behavior, face mask filtration mechanisms and efficiency, and environmental conditions.
| Research Focus | References | |
|---|---|---|
| Realistic simulation of expiratory events | Coughing | [ |
| Sneezing | [ | |
| Human activities | Head movement | [ |
| Walking | [ | |
| Accurate representation of the interaction between droplets and the RPD’s internal structure | [ | |
| Leakage flows | [ | |
| Representation of CO2 levels | [ | |
| Validation with experimental data | [ | |
| Effects of environmental conditions | Wind speed | [ |
| Relatively humidity/particulate matters | [ | |
| Room ventilation | [ | |
Figure 6Respirator shortage and medical waste increase as a consequence of COVID-19.
Summary of the most commonly used respirator decontamination methods [47,322,323,325,327,335,336,339,340,341,344,347,350,351,352,353,354,355,356,357].
| Decontamination Method | Disinfection Method | Anti-Pathogen and Performance Impact | Feasibility and Limitations |
|---|---|---|---|
| Ultraviolet germicidal irradiation (UVGI) |
Effective against SARS-CoV-2 Usable for multiple decontamination cycles Filter efficiency and fit maintained |
Short treatment time Specialized equipment and training needed Dedicated space required Not suitable for home use Appropriate radiation intensity needed | |
| Moist heat |
Effective against SARS-CoV-2 Usable for multiple decontamination cycles Filter efficiency and fit may be altered |
Short treatment time Easy to use Low cost Easily available equipment Appropriate heat and humidity needed | |
| Vaporized H2O2 (VHP) |
Effective against SARS-CoV-2 Usable for multiple decontamination cycles Filter efficiency and fit may be altered |
Long treatment time Dedicated space required Residual odor Specialized equipment and training needed | |
| Home bleach |
No adept evidence against SARS-CoV-2 Restricted numbers of decontamination cycles Filter efficiency and fit may alter |
Easily available equipment Easy to use Effectiveness may vary Residual odor |
Figure 7(a) Scanning electron microscope images of fibrous materials containing novel secondary nanostructures. Reprinted with permission from [377] © 2019, Wiley; [378] © 2019, American Chemical Society; [380] © 2016, Royal Society of Chemistry; [381] © 2020, American Chemical Society; [382] © 2018, Royal Society of Chemistry; [383] © 2019, American Chemical Society. (b) Scanning electron microscope images of superhydrophobic fibrous materials. Reprinted with permission from [385] © 2020, Elsevier; [386] © 2020, American Chemical Society; [388] © 2017, Elsevier.
Figure 8(a) Jablonski diagram illustrating the photo-excitation process of PSs. Reprinted with permission from [412] © 2020, American Chemical Society. (b) Illustration of biocidal activity of face masks embedded with PS. Reprinted with permission from [412] © 2020, American Chemical Society. Chemical structures of (c) synthetic PSs embedded in fibrous materials, (d) bio-based or bio-derived PSs. Reprinted with permission from [437] © 2019, American Chemical Society; (e) conjugated oligomers and polymers with antiviral functions. Reprinted with permission from [440] © 2020, American Chemical Society.
Figure 9Incorporation of PSs into fibrous materials based on (a) conventional dyeing (i.e., electrostatic interaction): (i) photosensitizers dyed on polycationic cotton fabrics (reprinted with permission from [412] © 2020, American Chemical Society), (ii) photosensitizer dyed on wool/acrylic blended fibers (reprinted with permission from [427] © 2019, American Chemical Society); (b) chemical modification: (i) chemical grafting of photoactive anthraquinone moiety on silk fibroin/cellulose acetate blend nanofibrous mem-brane (reprinted with permission from [419] © 2020, American Chemical Society), (ii) chemical grafting of rose Bengal on cotton fabrics (reprinted with permission from [428] © 2020, Elsevier); (c) guest-host adsorption (reprinted with permission from [429] © 2020, Elsevier).